Loading company…
Selventa analyzes molecular patient data to speed up therapeutic and diagnostic decisions for pharma and biotech partners.
Based in Cambridge, US, Selventa analyzes molecular patient data to help pharmaceutical and biotechnology partners accelerate development and make clearer decisions on therapeutics and diagnostics. It is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in